The blocking of endocannabinoids has been implicated in the early pathology of Alzheimer's disease in a new study led by investigators at the Stanford University School of Medicine. The former are signaling substances that are the brain's internal versions of the psychoactive chemicals in marijuana and hashish. A substance called A-beta - strongly suspected to play a key role in Alzheimer's because it's the chief constituent of the hallmark clumps dotting the brains ...
Read More
No comments:
Post a Comment